More than 500 Life Science technology areas of expertise can currently be accessed directly through LTN's network. Companies we have worked with include Pfizer, GSK, Roche, Sanofi-Pasteur, Sankyo among others.

London, the East and the South East's life sciences sector include large pharmaceutical companies, world-class research entities and 82 core life science companies that are home-grown and span entrepreneurial start-ups to more established biotechnology companies.

The healthcare sector contributes £5.8 billion to London's economy, representing 7% of its GDP. London hosts five medical schools across more than 15 hospital sites and 98 hospitals; which is the provision of more medical facilities than Paris, New York or Geneva. 60% of all clinical trials in Europe are carried out in the UK with London being the major centre for clinical trials in the UK. London hosts UK and European regulators including MCA, MDA and EMEA for product approval across Europe. London is the leading European destination for inward investment in pharmaceuticals.

Successful transfer of technologies through LTN in the life sciences sector include:

HFL works with St George's University of London and Royal Holloway University of London on detecting 'gene doping' in athletes and racehorses. Read more

Mesophotonics successfully collaborates with researchers from University College London, Imperial College London, and the University of Surrey to broaden the application of their products. Read more

York Pharma and St George's Biomics Centre collaborate on skin diagnostics. Read more

Canesis and University College London join forces on infection-control textile. Read more

Isohelix Ltd and the London School of Hygiene & Tropical Medicine join forces. Read more